Skip to content

Neutrophil to lymphocyte ratio as a prognostic marker in acute organophosphorus poisoning.

Neutrophil to lymphocyte ratio as a prognostic marker in acute organophosphorus poisoning. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/074030
Enrollment
98
Registered
2024-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T579- Toxic effect of unspecified inorganic substance

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Utkarsh Pradeep
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the consenting patients of 18 years and above who give a reliable history of oral ingestion of organophosphorus compounds, attending casualty or getting admitted within 24 hours of ingestion in medicine ward or medicine intensive care unit of DMIHER Wardha

Exclusion criteria

Exclusion criteria: 1. Patients refusing informed consent 2. Patients who have exposure to poisonous and compounds other than organophosphorus 3. Patients with severe chronic comorbidities, including liver cirrhosis, symptomatic heart failure (New York Heart Association class III or IV), end stage chronic kidney disease (on regular hemodialysis) and chronic obstructive pulmonary disease 4. Patients suffering from malignancies

Design outcomes

Primary

MeasureTime frame
To estimate the neutrophil to lymphocyte ratio in patients with organophosphorus poisoning and correlate the neutrophil lymphocyte ratio with severity of organophosphorus poisoning by Nambaet classification, Peradeniya organophosphorus poisoning scale and bardin classification Timepoint: On the day of admission (day 0)

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr. Utkarsh Pradeep

Datta Meghe Institute Of Higher Education and Research

anjuk.9c@gmail.com9579691988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026